CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$10,985
-35.4%
99,4160.0%0.00%
Q3 2022$17,000
-34.6%
99,4160.0%0.00%
Q2 2022$26,000
-7.1%
99,416
+121.1%
0.00%
Q4 2021$28,000
-39.1%
44,9590.0%0.00%
Q3 2021$46,000
-95.1%
44,959
-91.3%
0.00%
Q2 2021$943,000
-7.5%
515,021
-0.5%
0.00%
Q1 2021$1,020,000
+82.5%
517,389
+15.7%
0.00%
Q4 2020$559,000
-35.5%
447,025
-7.0%
0.00%
Q3 2020$866,000
-37.4%
480,716
+191.7%
0.00%
-100.0%
Q2 2020$1,383,000
+56.6%
164,814
-2.1%
0.00%0.0%
Q1 2020$883,000
+3.2%
168,388
+7.5%
0.00%
Q4 2019$856,000
+27.8%
156,594
+14.0%
0.00%
Q3 2019$670,000
-29.7%
137,4150.0%0.00%
-100.0%
Q2 2019$953,000
+10.4%
137,415
+10.7%
0.00%0.0%
Q1 2019$863,000
+36.3%
124,103
+14.5%
0.00%
Q4 2018$633,000
-23.6%
108,363
-1.1%
0.00%
-100.0%
Q3 2018$828,000
+49.5%
109,5730.0%0.00%
Q2 2018$554,000
-6.3%
109,573
+13.1%
0.00%
Q1 2018$591,000
-14.1%
96,8730.0%0.00%
-100.0%
Q4 2017$688,000
+29.3%
96,873
+30.4%
0.00%
Q3 2017$532,000
+13.4%
74,3000.0%0.00%
Q2 2017$469,00074,3000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders